Shares of prominent vaccine makers plunged Thursday after President-elect Donald Trump announced his pick of Robert F.
President-elect Donald Trump said he’s tapping Robert F. Kennedy Jr., to run the Department of Health and Human Services, a ...
Shares of vaccine makers fell as President-elect Donald Trump nominated Robert F. Kennedy Jr., a prominent vaccine skeptic, ...
Shares of vaccine makers fell on reports that President-elect Donald Trump is expected to nominate Robert F. Kennedy Jr., a ...
Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
Stocks linked to vaccine developers such as Moderna, Pfizer and Novavax tanked in the leadup ... has also falsely claimed ...
Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...
GlobalData on MSN2d
FDA clears Novavax to resume trials of Covid-19 and flu combo vaccineThe FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused ...
Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...
Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...
The FDA has lifted its clinical hold on Novavax's combined COVID-19 and influenza vaccine trial, finding no link between the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback